NYSE:LLYPharmaceuticals
Eli Lilly (LLY) Unveils Lilly TuneLab AI Platform With US$1 Billion Data Investment
Eli Lilly (LLY) saw notable developments in September, with the launch of Lilly TuneLab, an AI/ML platform designed to enhance drug discovery, showcasing the company's commitment to technological innovation. The company's recent positive clinical trial results, including Jaypirca's Phase 3 success, and the FDA's Breakthrough Therapy designation for olomorasib, further reinforced its robust pipeline. Amid these events, LLY's share price rose 20% over the past month, echoing a strong market...